The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma
Open Access
- 21 December 2007
- journal article
- Published by Springer Nature in BMC Cancer
- Vol. 7 (1) , 232
Abstract
Background: The heat shock proteins (HSPs) 27-kDa (HSP27) and 72-kDa (HSP72), are ubiquitous chaperone molecules inducible in cells exposed to different stress conditions. Increased level of HSPs are reported in several human cancers, and found to be associated with the resistance to some anticancer treatments and poor prognosis. However, there is no study of the relationship between HSPs expression and patient's prognosis in intrahepatic cholangiocarcinoma (IHCCA). In this exploratory retrospective study, we investigated the expressions of HSP27 and HSP72 as potential prognostic factors in IHCCA. Methods: Thirty-one paraffin-embedded samples were analyzed by immunohistochemical methods using HSP27 and HSP72 monoclonal antibodies. Proliferation rate was assessed in the same specimens by using monoclonal antibody against phosphorylated histone H3 (pHH3). Fisher's exact test was used to assess the hypothesis of independence between categorical variables in 2 × 2 tables. The ANOVA procedure was used to evaluate the association between ordinal and categorical variables. Estimates of the survival probability were calculated using the Kaplan-Meier method, and the log rank test was employed to test the null hypothesis of equality in overall survival among groups. The hazard ratio associated with HSP27 and HSP72 expression was estimated by Cox hazard-proportional regression. Results: The expression of HSP27 was related to mitotic index, tumor greatest dimension, capsular and vascular invasion while the expression of HSP72 was only related to the presence of necrosis and the lymphoid infiltration. Kaplan-Maier analysis suggested that the expression of HSP27 significantly worsened the patients' median overall survival (11 ± 3.18 vs 55 ± 4.1 months, P-value = 0.0003). Moreover HSP27-positive patients exhibited the worst mean survival (7.0 ± 3.2 months) in the absence of concomitant HSP72 expression. Conclusion: The expression of HSP27, likely increasing cell proliferation, tumor mass, vascular and capsular invasion, might promote aggressive tumor behaviour in IHCCA and decrease patients' survival. Immunohistochemical detection of HSP27 on routine sections may provide a reliable prognostic marker for IHCCA able to influence the therapeutic strategies for this cancer.Keywords
This publication has 51 references indexed in Scilit:
- Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cellsMolecular Cancer Therapeutics, 2007
- Cholangiocarcinoma: Modern advances in understanding a deadly old diseaseJournal of Hepatology, 2006
- Small interference RNA targeting heat‐shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase‐3 activation in vitroBJU International, 2006
- CholangiocarcinomaNature Clinical Practice Gastroenterology & Hepatology, 2006
- Expressions of HSP70 and HSP27 in Hepatocellular CarcinomaJournal of Korean Medical Science, 2005
- Expression of heat‐shock proteins hsp27, hsp70 and hsp90 in malignant epithelial tumour of the ovariesAPMIS, 2003
- Expression of the 27-kDa heat shock protein (HSP27) in gastric carcinomas and adjacent normal, metaplastic, and dysplastic gastric mucosa, and its prognostic significanceJournal of Cancer Research and Clinical Oncology, 2002
- Immunotherapy of cancer using heat shock proteinsFrontiers in Bioscience-Landmark, 2002
- A Study of Heat Shock Protein 27 in Endometrial CarcinomaGynecologic Oncology, 1999
- Bcl-2 and Hsp27 act at different levels to suppress programmed cell deathOncogene, 1997